PF-04634817 Renal Impairment Study

Single 50 mg dose administered to subjects with normal renal function (creatinine clearance greater than or equal to 90 ml/min)

Single 50 mg dose administered to subjects with mild renal impairment (creatinine clearance 60-89 ml/min)

Single 50 mg dose administered to subjects with moderate renal impairment (creatinine clearance 30-59 ml/min)

Single 50 mg dose administered to subjects with severe renal impairment (creatinine clearance 15-29 ml/min)